Inventor · disambiguated record
Michinori Kohara
Also filed as: KOHARA MICHINORI
21 granted patents·16 pending applications·44 citations·filing 1993–2024
91Inventor score
Files withTOKYO METROPOLITAN INST MEDICAL SCIENCE13KOHARA MICHINORI5CHUGAI PHARMACEUTICAL CO LTD2PEPTIDREAM INC2PRISM PHARMA CO LTD2
Top patents by PatentIndex Score
37 records- 0167US5641654ANon-A non-B hepatitis specific antigen and its use in hepatitisTONEN CORP·Filed 1993·Granted Jun 24, 1997·23 cites·8 claims
- 0266US2024415905A1Medication for influenzaTOKYO METROPOLITAN INST MEDICAL SCIENCE·Filed 2024·Application pending·0 cites
- 0366US2025041326A1Therapeutic agent for refractory viral infectionsTOKYO METROPOLITAN INST MEDICAL SCIENCE·Filed 2022·Application pending·0 cites
- 0460US6429355B1Hepatitis C animal modelTOKYO METROPOLITAN INST OF MED·Filed 2000·Granted Aug 6, 2002·5 cites·3 claims
- 0559US11491219B2Nasal hepatitis B vaccine composition and method for producing sameTOKO YAKUHIN KOGYO KK·Filed 2018·Granted Nov 8, 2022·0 cites·10 claims
- 0658US10632187B2Hemagglutinin-binding peptidePEPTIDREAM INC·Filed 2019·Granted Apr 28, 2020·0 cites·10 claims
- 0755US11051496B2Urokinase-type plasminogen activator transgenic mouseTOKYO METROPOLITAN INST MEDICAL SCIENCE·Filed 2018·Granted Jul 6, 2021·0 cites·11 claims
- 0855US6201166B1Transgenic mouse hepatitis C virus model comprising a hepatitis C viral fragmentTOKYO METROPOLITAN INST OF MED·Filed 1997·Granted Mar 13, 2001·8 cites·1 claims
- 0954US9000136B2Recombinant vaccinia virus having hepatitis C virus geneKOHARA MICHINORI·Filed 2009·Granted Apr 7, 2015·0 cites·5 claims
- 1053US9700569B2Prevention or treatment agent for hepatic fibrosisPRISM PHARMA CO LTD·Filed 2013·Granted Jul 11, 2017·0 cites·4 claims
- 1151US12458658B2Composition for inhibiting replication of hepatitis B virusTOKYO METROPOLITAN INST MEDICAL SCIENCE·Filed 2019·Granted Nov 4, 2025·0 cites·1 claims
- 1251US8609403B2Polynucleotide derived from novel hepatitis C virus strain and use thereofKOHARA MICHINORI·Filed 2010·Granted Dec 17, 2013·0 cites·10 claims
- 1350US9955675B2Urokinase-type plasminogen activator transgenic mouseTOKYO METROPOLITAN INST MEDICAL SCIENCE·Filed 2013·Granted May 1, 2018·0 cites·2 claims
- 1450US2023295655A1Recombinant vaccinia virusTOKYO METROPOLITAN INST MEDICAL SCIENCE·Filed 2021·Application pending·0 cites
- 1549US10265331B2Prevention or treatment agent for hepatic fibrosisPRISM PHARMA CO LTD·Filed 2017·Granted Apr 23, 2019·0 cites·2 claims
- 1648US12280099B2Dengue virus vaccineTOKYO METROPOLITAN INST MEDICAL SCIENCE·Filed 2020·Granted Apr 22, 2025·0 cites·11 claims
- 1748US8957199B2Oligoribonucleotide or peptide nucleic acid capable of inhibiting activity of hepatitis C virusKOHARA MICHINORI·Filed 2009·Granted Feb 17, 2015·0 cites·15 claims
- 1848US2023174586A1Strain dis-derived recombinant vaccinia virus having novel influenza virus-derived hemagglutinin protein geneTOKYO METROPOLITAN INST MEDICAL SCIENCE·Filed 2019·Application pending·0 cites
- 1948US2014178856A1Polynucleotide derived from novel hepatitis c virus strain and use thereofPHOENIXBIO CO LTD·Filed 2013·Application pending·0 cites
- 2047US2010152433A1Antiviral agentMICHINORI KOHARA·Filed 2008·Application pending·0 cites
- 2146US10328143B2Hemagglutinin-binding peptidePEPTIDREAM INC·Filed 2015·Granted Jun 25, 2019·0 cites·11 claims
- 2246US6524853B1Vector expressing the full-length gene of RNA virus and use thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 1999·Granted Feb 25, 2003·6 cites·11 claims
- 2346US2009214587A1Recombinant virus and use thereofPOST GENOME INST CO LTD·Filed 2005·Application pending·0 cites
- 2446US2009148424A1Reversibly immortalized mammalian liver cells and use thereofKOBAYASHI NAOYA·Filed 2004·Application pending·0 cites
- 2545US2020345800A1Medication for influenzaTOKYO METROPOLITAN INST MEDICAL SCIENCE·Filed 2018·Application pending·0 cites
- 2644US8466273B2Hepatitis C virus inhibitorsKOHARA KYOKO·Filed 2008·Granted Jun 18, 2013·0 cites·6 claims
- 2744US2018161421A1Recombinant vaccinia virus having hemagglutinin protein genes derived from novel influenza virusesTOKYO METROPOLITAN INST MEDICAL SCIENCE·Filed 2018·Application pending·0 cites
- 2843US2003143528A1Vector for analayzing replication mechanism of rna virus and use thereofFiled 2001·Application pending·0 cites
- 2939US2004101827A1Methods of infection with hepatitis c virusFiled 2001·Application pending·0 cites
- 3039US2006128617A1Oligoribonucleotide or peptidic nucleic acid inhibiting function of hepatitis c virusCHUGAI PHARMACEUTICAL CO LTD·Filed 2004·Application pending·0 cites
- 3138US11517741B2Electrodes for electroporationTOKYO METROPOLITAN INST MEDICAL SCIENCE·Filed 2017·Granted Dec 6, 2022·0 cites·6 claims
- 3238US2006174354A1Hcv gene transgenic animalKOHARA MICHINORI·Filed 2002·Application pending·0 cites
- 3338US2013288338A1Recombinant vaccinia virus having hemagglutinin protein genes derived from novel influenza virusesKOHARA MICHINORI·Filed 2011·Application pending·0 cites
- 3436US2021228712A1Hepatitis b vaccineTOKYO METROPOLITAN INST MEDICAL SCIENCE·Filed 2018·Application pending·0 cites
- 3531US10160979B2Pharmaceutical composition for treatment and/or prevention of hepatitis CTOKYO METROPOLITAN INST MEDICAL SCIENCE·Filed 2015·Granted Dec 25, 2018·0 cites·7 claims
- 3629US6639053B1HCV-derived RNA polymerase geneTOYODA TETSUYA·Filed 1999·Granted Oct 28, 2003·2 cites·6 claims
- 3729US5662906ANon-a non-b hepatitis-specific antigen and its use in hepatitis diagnosisTONEN CORP·Filed 1995·Granted Sep 2, 1997·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Michinori Kohara files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →